Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash [Seeking Alpha]
Axonics, Inc. (AXNX)
Last axonics, inc. earnings: 3/4 04:01 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
The legal clash between Axonics and Medtronic may endanger Boston Scientific's ability to commercialize Axonics' products in the near future. BSX is currently trading at historically high prices. Given the limited upside and the recent share price rally, Boston Scientific is overvalued. Thesis Boston Scientific Corporation ( NYSE: BSX ) delivered good results in their FY2023 report , within its 2024-2026 guidance the company expects 8-10% sales growth which already accounts with the recent FDA approval of FARAPULSE as well as a revenue increase derived from the Axonics' deal from 2025. Boston Scientific's share price has observed a 17.79% increase year to date, with the common shares standing at $68.13 at the time of writing. Considering the company's historical growth and their expected growth forward, Boston Scientific is currently overvalued. Furthermore, if the legal clash between Axonics and Medtronic continues, I would expect, it will endanger Boston Scientific's capaci
Show less
Read more
Impact Snapshot
Event Time:
AXNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXNX alerts
High impacting Axonics, Inc. news events
Weekly update
A roundup of the hottest topics
AXNX
News
- FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal [Reuters]Reuters
- FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal [Yahoo! Finance]Yahoo! Finance
- UPDATE 1-FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal [Yahoo! Finance]Yahoo! Finance
- All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- Insights into the Future of Neurology Devices: Exploring the Global Market Report by BCC Research [Yahoo! Finance]Yahoo! Finance
AXNX
Earnings
- 10/30/23 - Beat
AXNX
Sec Filings
- 4/29/24 - Form 10-K/A
- 4/4/24 - Form 8-K
- 3/25/24 - Form 8-K
- AXNX's page on the SEC website